Profil
Marius Nacht was the founder of Check Point Software Technologies Ltd., founded in 1993, where the title held was Chairman from 2015 to 2020.
Mr. Nacht was the founder of DayTwo Ltd., founded in 2015, where the title held was Director.
Mr. Nacht is the founder of Baccine Ltd., founded in 2021.
Mr. Nacht is also the founder of Aummune Ltd...
Mr. Nacht currently holds the position of Chairman at Regenera Pharma Ltd. Mr. Nacht currently holds the position of Advisor at Firstminute Capital LLP.
Mr. Nacht completed an undergraduate degree at The Hebrew University of Jerusalem in 1983.
Mr. Nacht completed a graduate degree at Tel-Aviv University in 1987.
Aktive Positionen von Marius Nacht
| Unternehmen | Position | Beginn |
|---|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company, which develops novel drugs | Vorsitzender | - |
Aummune Ltd.
Aummune Ltd. BiotechnologyHealth Technology Develops pre-clinical cancer therapeutics | Gründer | - |
Firstminute Capital
Firstminute Capital Investment ManagersFinance Firstminute Capital seeks investment opportunities in companies located in the Europe primarily in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital transactions with an investment size of EUR 1 - 3 million. The firm acts as lead investor. | Berater | - |
Ehemalige bekannte Positionen von Marius Nacht
| Unternehmen | Position | Ende |
|---|---|---|
| CHECK POINT SOFTWARE TECHNOLOGIES LTD. | Gründer | 03.08.2020 |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Gründer | - |
DayTwo Ltd.
DayTwo Ltd. Medical/Nursing ServicesHealth Services Provides personalized nutrition and actionable insights that allows to live healthier and maintain normal blood sugar levels | Gründer | - |
Ausbildung von Marius Nacht
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Check Point Software Technologies Ltd.
Check Point Software Technologies Ltd. Internet Software/ServicesTechnology Services Develops network security software products | Technology Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company, which develops novel drugs | Health Technology |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
DayTwo Ltd.
DayTwo Ltd. Medical/Nursing ServicesHealth Services Provides personalized nutrition and actionable insights that allows to live healthier and maintain normal blood sugar levels | Health Services |
Firstminute Capital
Firstminute Capital Investment ManagersFinance Firstminute Capital seeks investment opportunities in companies located in the Europe primarily in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital transactions with an investment size of EUR 1 - 3 million. The firm acts as lead investor. | Finance |
Aummune Ltd.
Aummune Ltd. BiotechnologyHealth Technology Develops pre-clinical cancer therapeutics | Health Technology |
















